Hoffmeister H M, Jur M, Wendel H P, Heller W, Seipel L
Medizinische Klinik, Eberhard-Karls-Universität Tübingen, Germany.
Circulation. 1995 May 15;91(10):2520-7. doi: 10.1161/01.cir.91.10.2520.
Unstable angina pectoris is frequently associated with intracoronary thrombus formation. In a prospective study, we investigated in 35 patients with unstable angina pectoris markers of coagulation and the kallikrein-kinin and fibrinolytic systems in the acute and postacute phases.
We determined serially in the patients up to 10 days after admission factor XII and the beta-factor XIIa inhibition, kallikrein-like activity, prekallikrein, C1-esterase inhibitor, kallikrein inhibition, high molecular weight kininogen as indicators of the contact phase and bradykinin generation, thrombin-antithrombin III (TAT) complex as marker of the activated coagulation cascade, fibrinogen, plasminogen, plasminogen activator inhibitor-1 (PAI-1), tissue-type plasminogen activator (TPA), and D-dimers as indicators of the fibrinolytic system. Data were compared with those from control subjects (n = 25) and from patients with stable angina pectoris (n = 25). In patients with unstable angina pectoris, initially the contact phase and the kallikrein-kinin system were markedly elevated (factor XII, 96 +/- 5% versus 117 +/- 5%; kallikrein-like activity, 35.7 +/- 2.9 versus 27.4 +/- 1.3 U/L; high molecular weight kininogen, 52.7 +/- 5.2% versus 87.7 +/- 3.9%; P < .01 versus control subjects). Contact-phase activation persisted for the following 10 days, whereas the initially enhanced bradykinin generation normalized after 2 days. Furthermore, we had evidence of a hypercoagulative state (TAT, 10.9 +/- 3.1 versus 4.5 +/- 0.7 micrograms/L, P < .05; D-dimer, 474 +/- 81 versus 272 +/- 71 ng/mL) persisting longer than the clinically symptomatic period in association with disturbed fibrinolysis (TPA, 15.9 +/- 1.9 versus 5.1 +/- 0.4 ng/mL; P < .01; PAI-1, 9.9 +/- 2.6 versus 4.6 +/- 1.6 AU/mL; P = NS) in the presence of elevated fibrinogen levels.
Our data indicate that in patients with unstable angina pectoris, intracoronary thrombus formation is associated with a hypercoagulative state, including activation of the contact phase and of the kallikrein system and increased bradykinin generation. The persistence of this hypercoagulative state, together with a disturbed fibrinolysis, might indicate an increased risk for further coronary events.
不稳定型心绞痛常与冠状动脉内血栓形成有关。在一项前瞻性研究中,我们对35例不稳定型心绞痛患者在急性期和急性期后凝血、激肽释放酶 - 激肽系统及纤溶系统的标志物进行了研究。
我们在患者入院后长达10天的时间里连续测定了因子XII、β - 因子XIIa抑制物、类激肽释放酶活性、前激肽释放酶、C1酯酶抑制物、激肽释放酶抑制物、高分子量激肽原作为接触相和缓激肽生成的指标,凝血酶 - 抗凝血酶III(TAT)复合物作为激活凝血级联反应的标志物,纤维蛋白原、纤溶酶原、纤溶酶原激活物抑制剂 - 1(PAI - 1)、组织型纤溶酶原激活物(TPA)以及D - 二聚体作为纤溶系统的指标。将数据与对照组(n = 25)和稳定型心绞痛患者(n = 25)的数据进行比较。在不稳定型心绞痛患者中,最初接触相和激肽释放酶 - 激肽系统明显升高(因子XII,96±5%对117±5%;类激肽释放酶活性,35.7±2.9对27.4±1.3 U/L;高分子量激肽原,52.7±5.2%对87.7±3.9%;与对照组相比P <.01)。接触相激活在接下来的10天持续存在,而最初增强的缓激肽生成在2天后恢复正常。此外,我们有证据表明高凝状态持续存在(TAT,10.9±3.1对4.5±0.7微克/升,P <.05;D - 二聚体,47